Announcements & Circulars-Alphamab Oncology

English 中文简体中文繁体

English 中文简体中文繁体

Investors

Information Disclosure

Listing Documents

Financial Reports

Announcements & Circulars

Company Presentation

Corporate Governance

Stock Information

Corporate Communications

Email Subscription

Announcements & Circulars

The announcement begins in December 2019

VOLUNTARY ANNOUNCEMENT - EXCLUSIVE COLLABORATION WITH CSPC IN RELATION TO THE DEVELOPMENT AND COMMERCIALIZATION OF KN026 IN MAINLAND CHINA 2021-08-23
DATE OF BOARD MEETING 2021-08-16
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2021 2021-08-05
VOLUNTARY ANNOUNCEMENT - ABSTRACTS AND E-POSTERS OF RESEARCH UPDATES ON KN046 AND KN026 FOR PRESENTATION AT ESMO CONGRESS 2021 2021-07-26
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2021 2021-07-06
POLL RESULTS OF ANNUAL GENERAL MEETING HELD ON JUNE 11, 2021 2021-06-11
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2021 2021-06-03
CONNECTED TRANSACTION ANNOUNCEMENT - TECHNOLOGY DEVELOPMENT COLLABORATION WITH SUZHOU ALPHAMAB ON JSKN003 PROJECT AND KN062 COVID-19 ANTIBODY PROJECT 2021-05-27
Next Day Disclosure Return 2021-05-26
2020 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT 2021-05-20

16 17 18 19 20 21 22